News for 'pharmaceutical industry'

In UNGA address, PM Modi pushes for reforms

In UNGA address, PM Modi pushes for reforms

Rediff.com26 Sep 2020

In his pre-recorded video statement to the landmark General Debate of the 75th session of the United Nations General Assembly, Modi said the stability in the United Nations and empowerment of the world body are essential for the welfare of the world.

Ayushman Bharat may help patients access life-saving drugs

Ayushman Bharat may help patients access life-saving drugs

Rediff.com16 May 2018

'We have often heard the mythical argument that patents block access to life-saving drugs, but only 5% of medicines from multinational companies are under patent protection in India.' 'Where these patented products are beyond the reach of Indian patients, the companies have programmes to facilitate access to their drugs, for free or for a fraction of the price,' points out Ranjana Smetacek, former director general, Organisation of Pharmaceutical Producers of India.

India's Russian imports up 3.5 times on oil buys despite Western pressure

India's Russian imports up 3.5 times on oil buys despite Western pressure

Rediff.com22 Jun 2022

On the back of rising crude oil purchases, India's bill for imports from sanctions-hit Russia jumped 3.5 times in a year in April to $2.3 billion, showed data from the commerce ministry. In April, India's crude oil imports from Russia were valued at $1.3 billion, 57 per cent of India's total inbound shipments from Russia. Other major imported items during the month included coal, soybean and sunflower oil, fertilisers, and non-industrial diamonds. That month, Russia was also the fourth-largest crude petroleum supplier to India, after Iraq, Saudi Arabia, and the United Arab Emirates (UAE).

Govt gifts Rs 1.45-trillion incentive for 10 manufacturing sectors

Govt gifts Rs 1.45-trillion incentive for 10 manufacturing sectors

Rediff.com12 Nov 2020

The government hopes that the PLI schemes would provide 200,000-300,000 direct employment over five years, according to sources in the know.

Do we need to take multiple vaccine doses before 2024?

Do we need to take multiple vaccine doses before 2024?

Rediff.com5 Jan 2021

With the virus mutating, can vaccines be assumed safe and effective in the long run?

Compliance worries hit shares in India's top two drugmakers

Compliance worries hit shares in India's top two drugmakers

Rediff.com9 Nov 2015

Credit Suisse analysts cut their rating on Sun Pharma stock to 'neutral' from 'outperform

Rakesh Jhunjhunwala rejigs portfolio in Q2; ups stake in Lupin, Tata Motors

Rakesh Jhunjhunwala rejigs portfolio in Q2; ups stake in Lupin, Tata Motors

Rediff.com30 Oct 2020

The duo bought additional shares in pharmaceutical companies Lupin and Jubilant Life Sciences, along with Agro Tech Foods and NCC during Q2FY21

Stocks that shine year after year

Stocks that shine year after year

Rediff.com31 Dec 2014

The S&P BSE Sensex has rallied about 28 per cent in 2014, after formation of a stable government at the Centre.

'Urban Naxals' trying to enter Gujarat: Modi targets AAP

'Urban Naxals' trying to enter Gujarat: Modi targets AAP

Rediff.com10 Oct 2022

The Arvind Kejriwal-led AAP is trying to make inroads into BJP-ruled Gujarat where the assembly polls are due later this year.

India defers FTA talks with European Union

India defers FTA talks with European Union

Rediff.com6 Aug 2015

Negotiators from were expected to meet in New Delhi on August 28.

Corporate air travel takes wing on economic revival

Corporate air travel takes wing on economic revival

Rediff.com15 Feb 2021

Online travel portals and airlines say the demand from companies is being led by essential services sectors like pharmaceutical, oil and gas, and power.

Share of family-owned firms in total market capitalisation rises to 64.5%

Share of family-owned firms in total market capitalisation rises to 64.5%

Rediff.com4 Jan 2021

The growth was led by family-owned companies and business groups with presence in pharmaceuticals, information technology services, and consumer products.

'Profiting from Pain': Covid created new billionaire every 30 hrs

'Profiting from Pain': Covid created new billionaire every 30 hrs

Rediff.com23 May 2022

Releasing a report titled 'Profiting from Pain' in Davos, the rights group further said as the cost of essential goods rises faster than it has in decades, billionaires in the food and energy sectors are increasing their fortunes by $1 billion every two days.

After April shock, drug sales improve in May

After April shock, drug sales improve in May

Rediff.com20 May 2020

The industry feels two factors have played a role in improving the offtake and reducing trade inventory - one is that the supply chain in pharmaceuticals has more or less stabilised, and secondly, with lockdown curbs easing and OPDs opening, some demand has grown at the consumer end as well.

Why prices of vitamin C, antibiotics could shoot up

Why prices of vitamin C, antibiotics could shoot up

Rediff.com14 Dec 2019

The government said that "in exercise of extraordinary powers in public interest, conferred by paragraph 19 of the DPCO, 2013", the ceiling prices of 21 key formulations had been increased. These formulations include common medicines like BCG vaccines, penicillin, malaria and leprosy medicines (Dapsone), life-saving drugs like Furosemide (used to treat fluid build-up due to heart failure, liver scarring, or kidney disease), vitamin C, some common antibiotics, and anti-allergy medicines.

Ranbaxy's top executives in the US resign

Ranbaxy's top executives in the US resign

Rediff.com14 Oct 2014

US country head, key departmental heads leave; more likely to follow.

How Shark Tank India 1 Winners Fared

How Shark Tank India 1 Winners Fared

Rediff.com14 Jan 2023

Of the 23 companies, eight have raised funds after Shark Tank India.

Ask Ajit: 'Help! I have inherited these stocks...'

Ask Ajit: 'Help! I have inherited these stocks...'

Rediff.com23 Nov 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

India, US to enhance engagement on IPR

India, US to enhance engagement on IPR

Rediff.com25 Jan 2015

India and the US on Sunday agreed to enhance their engagement on intellectual property rights, a vexed issue between the two countries.

UN chief lauds India's COVID-19 vaccine assistance to nations

UN chief lauds India's COVID-19 vaccine assistance to nations

Rediff.com29 Jan 2021

India has airlifted more than 6 million COVID-19 doses to nine countries in Phase-I under its initiative termed "Vaccine Maitri".

Bajaj biggest gainer, Anil Ambani biggest loser in Modi Sarkar

Bajaj biggest gainer, Anil Ambani biggest loser in Modi Sarkar

Rediff.com2 Apr 2019

The Hinduja Group, Mukesh Ambani, Murugappa, and the Adani groups were the other gainers in the Modi regime, while Naveen Jindal and Sun Pharma groups saw the most erosion in their m-cap in the last five years, reports Krishna Kant.

Democratic debate: Sanders, Clinton face off during New Hampshire debate

Democratic debate: Sanders, Clinton face off during New Hampshire debate

Rediff.com5 Feb 2016

Hillary Clinton and Bernie Sanders tangled in their first one-on-one debate over how to achieve liberal goals such as health care for all and a better education system.

'Market rally more likely to sustain than come to grinding halt'

'Market rally more likely to sustain than come to grinding halt'

Rediff.com1 Oct 2021

'Private banks are well-placed to deliver good performance over the next six months.'

'Whatever I have is because of India'

'Whatever I have is because of India'

Rediff.com24 May 2018

'15, 17 years back we were not even in existence in the US. Today nearly 1/3 of prescriptions written comes from India.' 'India is showing that in a very competitive environment -- like the US and Europe -- our industry is doing very well.'

Human Review

Human Review

Rediff.com14 Jan 2022

Human presents an ugly truth -- that some people need to die a painful death in order to facilitate the process of finding a cure for deadly diseases, observes Utkarsh Mishra.

Ranbaxy sues US FDA for revoking drug approvals

Ranbaxy sues US FDA for revoking drug approvals

Rediff.com18 Nov 2014

FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte

Brexit brings bad news to Indian, global corporates

Brexit brings bad news to Indian, global corporates

Rediff.com24 Jun 2016

Some investors warned of a coming British or even global recession as sterling collapsed to hit its lowest since 1985.

Coronavirus: PM announces task force for economic rescue package

Coronavirus: PM announces task force for economic rescue package

Rediff.com19 Mar 2020

The task force, to be headed by Finance Minister Nirmala Sitharaman, will look at measures to limit economic hardship caused by the Covid-19 pandemic, he said in his address to the nation.

Sensex crosses 27K after 6 weeks, bluechips rule

Sensex crosses 27K after 6 weeks, bluechips rule

Rediff.com7 Oct 2015

Markets climb higher tracking global cues.

'Indian market one-eyed king in the land of the blind in 2022'

'Indian market one-eyed king in the land of the blind in 2022'

Rediff.com23 Sep 2022

'We have relatively strong growth and a healthy corporate earnings cycle as positives, but a worrisome current account deficit and high inflation as challenges.'

Why US' revocation may not have much effect on HCQs exports

Why US' revocation may not have much effect on HCQs exports

Rediff.com17 Jun 2020

This is because while the emergency authorisation for treating Covid was a recent move, the drug has been used since years for rheumatoid arthritis and autoimmune lupus.

Ask Ajit: 'Bought shares at peak; please advice'

Ask Ajit: 'Bought shares at peak; please advice'

Rediff.com30 Mar 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

COVID-19: You can SAVE your life!

COVID-19: You can SAVE your life!

Rediff.com14 Oct 2020

'Try to get in 30 to 60 minutes of a brisk walk every day, like my grandparents would do in the village -- twice a day they would go for morning walks and they would go after dinner.'

Hiring sentiment highest in India, 17% firms keen on freshers: Survey

Hiring sentiment highest in India, 17% firms keen on freshers: Survey

Rediff.com22 Sep 2021

Fresher hiring sentiment is highest in India, with 17 per cent employers keen on recruiting fresh graduates in the July to December 2021 period against 6 per cent globally. According to the Career Outlook Report by TeamLease EdTech, conducted across 18 sectors and 14 cities, the hiring sentiment in the country has registered a 2 percentage point increase over the February-April 2021 period. In terms of sectors, those that have been able to withstand the impact of the pandemic and witnessed a stronger hiring sentiment are information technology (31 per cent), telecommunication (25 per cent) and technology start-ups (25 per cent).

3rd wave: Govt creating 30-day stock of key Covid medicines

3rd wave: Govt creating 30-day stock of key Covid medicines

Rediff.com26 Jul 2021

'The Centre is planning to procure five million vials of Remdesivir ahead of the third wave. What's better is that this time, the government is paying us in advance,' said a senior executive of a Mumbai-based pharma player which makes Remdesivir. Sohini Das reports.

States given 1.28 cr PPEs, 3 cr N95s, 10 cr HCQ tablets: Centre

States given 1.28 cr PPEs, 3 cr N95s, 10 cr HCQ tablets: Centre

Rediff.com13 Aug 2020

In addition, 22,533 'Make in India' ventilators have been delivered to various states, Union territories and central institutions, the ministry said, adding that the Centre is also ensuring the installation and commissioning of the machines.

PM chairs meet on oxygen supply, availability

PM chairs meet on oxygen supply, availability

Rediff.com22 Apr 2021

PM also said that states must act against any hoarding of oxygen and directed officials to ensure that the oxygen supply to various states happens in a smooth, unhindered manner and called for fixing responsibility with the local administration in cases of obstruction.

Govt may now cap prices of antibiotics

Govt may now cap prices of antibiotics

Rediff.com7 Oct 2019

The intention of the government is to cap prices of drugs that are essential and which the public widely uses.

India's rich club grows to 1,103; Zepto's Kaivalya youngest in Hurun list

India's rich club grows to 1,103; Zepto's Kaivalya youngest in Hurun list

Rediff.com22 Sep 2022

One hundred and forty nine new individuals joined the rich list club of 1,103 Indians across 122 cities who cumulatively accumulated a wealth of Rs 100 trillion. Bengaluru -based Kaivalya Vohra, 19, of grocery delivery application Zepto is the youngest self-made and the youngest rich individual, according to IIFL Wealth Hurun India Rich List 2022. The report found 1,103 Indians with a networth of Rs 1,000 crore each - an increase of 62 per cent over five years. There are 221 billionaires (Rs 100 crore networth) in India on the 2022 list - down 16 compared with last year, while 13 people born in the 1990s made it to the list, all self-made.

Coronavirus crisis pushes India to work on drug security

Coronavirus crisis pushes India to work on drug security

Rediff.com26 Mar 2020

The current crisis has forced the government to announce measures to ensure that India becomes self-sustaining for any kind of bulk drug. The government says India will not depend on any other country for vital key ingredients for drugs within six years, reports Sheela Bhatt.